AI series: AI – the next, and necessary, stage in the SaaS/cloud-computing revolution
In the first of a series of articles on AI in logistics, we talk to ...
WTC: RIDE THE WAVEFDX: TOP EXEC OUTPEP: TOP PERFORMER KO: STEADY YIELD AND KEY APPOINTMENTAAPL: SUPPLIER IPOCHRW: SLIGHTLY DOWNBEAT BUT UPSIDE REMAINSDHL: TOP PRIORITIESDHL: SPECULATIVE OCEAN TRADEDHL: CFO REMARKSPLD: BEATING ESTIMATESPLD: TRADING UPDATEBA: TRUMP TRADE
WTC: RIDE THE WAVEFDX: TOP EXEC OUTPEP: TOP PERFORMER KO: STEADY YIELD AND KEY APPOINTMENTAAPL: SUPPLIER IPOCHRW: SLIGHTLY DOWNBEAT BUT UPSIDE REMAINSDHL: TOP PRIORITIESDHL: SPECULATIVE OCEAN TRADEDHL: CFO REMARKSPLD: BEATING ESTIMATESPLD: TRADING UPDATEBA: TRUMP TRADE
Hot on the heels of tying up a joint-venture with Maersk to introduce more blockchain activity to the container shipping sector, IBM has come together with Chinese supply chain firm Hejia to run a blockchain trial for the pharmaceuticals supply chain, and particularly address China’s “underdeveloped credit evaluation system”, which, it argues, “can make it difficult to raise short-term capital”. What this means in practice is that smaller retailers which supply drugs to Chinese hospitals will get paid quicker, thus accelerating the velocity of a supply chain in which speed can mean the difference between life and death.
Comment on this article